Showing results (2051-2060 of 3,796) with videos related to

Sort By:
Pageof 380
Oncoimmunology|February 1, 2020
Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compoundsDenis L Jardim, Débora De Melo Gagliato, Mina Nikanjam, et al.
Oncoimmunology|February 1, 2020
Therapeutic melanoma vaccine with cancer stem cell phenotype represses exhaustion and maintains antigen-specific T cell stemness by up-regulating BCL6Patrycja Czerwinska, Marcin Rucinski, Nikola Wlodarczyk, et al.
Oncoimmunology|February 1, 2020
Durable tumor regression in highly refractory metastatic KIT/PDGFRA wild-type GIST following treatment with nivolumabBrett A Schroeder, Karan Kohli, Ryan B O'Malley, et al.
Oncoimmunology|February 1, 2020
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 studyAlessio Cortellini, Sebastiano Buti, Melissa Bersanelli, et al.
Oncoimmunology|February 1, 2020
ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancerWenda Ye, Sreenivasulu Gunti, Clint T Allen, et al.
Oncoimmunology|October 26, 2020
RNA-electroporated T cells for cancer immunotherapyFernanda Pohl-Guimarães, Lan B Hoang-Minh, Duane A Mitchell
Oncoimmunology|October 26, 2020
Significantly different immunological score in lung adenocarcinoma and squamous cell carcinoma and a proposal for a new immune staging systemZiqing Zeng, Fan Yang, Yunliang Wang, et al.
Oncoimmunology|November 12, 2020
IAP inhibitor, Embelin increases VCAM-1 levels on the endothelium, producing lymphocytic infiltration and antitumor immunityKosei Nakajima, Yoshinori Ino, Rie Yamazaki-Itoh, et al.
Oncoimmunology|November 12, 2020
Regulatory approval of photoimmunotherapy: photodynamic therapy that induces immunogenic cell deathLígia C Gomes-da-Silva, Oliver Kepp, Guido Kroemer
Oncoimmunology|December 10, 2020
Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinomaChristopher Montemagno, Anais Hagege, Delphine Borchiellini, et al.
Pageof 380